000 | 01625 a2200493 4500 | ||
---|---|---|---|
005 | 20250513195301.0 | ||
264 | 0 | _c20000104 | |
008 | 200001s 0 0 eng d | ||
022 | _a0090-9556 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRiska, P S | |
245 | 0 | 0 |
_aBiotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. _h[electronic resource] |
260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cDec 1999 |
||
300 |
_a1434-47 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBile _xmetabolism |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aFeces _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucuronidase _xmetabolism |
650 | 0 | 4 |
_aHIV Reverse Transcriptase _xantagonists & inhibitors |
650 | 0 | 4 | _aHaplorhini |
650 | 0 | 4 | _aHydrolysis |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMass Spectrometry |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNevirapine _xblood |
650 | 0 | 4 | _aPan troglodytes |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xpharmacokinetics |
650 | 0 | 4 | _aSex Factors |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aJoseph, D P | |
700 | 1 | _aDinallo, R M | |
700 | 1 | _aDavidson, W C | |
700 | 1 | _aKeirns, J J | |
700 | 1 | _aHattox, S E | |
773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 27 _gno. 12 _gp. 1434-47 |
|
999 |
_c10526299 _d10526299 |